Prevalence and risk factors associated to tuberculosis and non-tuberculous mycobacterial infections in HIV-positive patients in Bogotá
Abstract
Introduction. Tuberculosis is one of the most widely distributed infectious diseases worldwide. It is the most common cause of mortality among AIDS patients. In Colombia, 12,918 tuberculosis cases were notified, and 926 deaths were reported in 2015.
Objective. To determine the prevalence and risk factors associated to mycobacterial infections in HIVpositive patients in two public hospitals from Bogotá.
Materials and methods. A prospective and descriptive study was carried out by an active search for tuberculosis cases and non-tuberculous mycobacterial infections in HIV-positive patients. We considered demographic, social, clinical, and personal habits as variables. Statistical analyses were done using Stata 13™ software.
Results. Three hundred and fifty six patients were included, 81.2% were men and 18.8% were women; the mean age was 36.5 years. Tuberculosis infection had a frequency of 19.9% (95% CI: 15.9-24.5%) and non-tuberculous mycobacterial infection had a 3.9% frequency (95% CI: 2.16-6.5%). Bivariate analysis showed a statistically significant association between tuberculosis infection and CD4+ T cell counts (p=0.003), viral load (p=0.008), antiretroviral therapy (p=0.014), and body mass index (BMI) <18 kg/m2 (p=0.000). In non-tuberculous mycobacterial infections there was a statistically significant
association with BMI (p=0.027) and CD4+ T cell counts (p=0.045).
Conclusion. Factors associated with an impaired immune system caused by HIV infection are an important risk factor for developing tuberculosis. The lack of antiretroviral therapy and the BMI were also important risk factors for tuberculosis.
Downloads
References
Corbett EL, Watt CJ, Walker N, Maher D, Williams BG, Raviglione MC, et al. The growing burden of tuberculosis: Global trends and interactions with the HIV epidemic. Arch Intern Med. 2003;163:1009-21. https://doi.org/10.1001/archinte.163.9.1009
Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC. Consensus statement. Global burden of tuberculosis: Estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA. 1999;282:677-86. https://doi.org/10.1001/jama.282.7.677
World Health Organization.Global tuberculosis report 2015. Fecha de consulta: 12 de febrero de 2016. Disponible en: apps.who.int/iris/bitstream/10665/191102/1/9789241565059_
eng.pdf
Organización Mundial de la Salud, Organización Panamericana de la Salud. Plan Estratégico Colombia Libre de Tuberculosis 2010-2015 para la expansión y fortalecimiento de la estrategia Alto a la TB. Fecha de consulta: 12 de octubre de 2015. Disponible en: http://www.paho.org/col/index.php?option=com_docman&task=doc_
download&gid=327&Itemid=
Ticona-Mendoza A, Iglesias-Quilca D. Tuberculosis en pacientes con VIH/SIDA. Acta Médica Peruana. 2008;25:247-54
Castiblanco CA, Wllman R. Coinfección de tuberculosis en pacientes con VIH/SIDA: un análisis según las fuentes de información en Colombia. Infectio. 2006;10:232-42.
Castiblanco CA, Llerena C. Tuberculosis en Colombia: análisis de la situación epidemiológica, año 2006. Infectio. 2008;12:159-73
Ministerio de Salud y Protección Social. Análisis de situación de salud. Colombia, 2014. Fecha de consulta: 3 de abril de 2016. Disponible en: https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/VS/ED/PSP/ASIS-2014-v11.pdf
Instituto Nacional de Salud. Boletín Epidemiológico Semanal. Diciembre 2015. Reporte No. 52. Fecha de consulta: 20 de febrero de 2016. Disponible en: http://www.ins.gov.co/boletin-epidemiologico/Boletn%20Epidemiolgico/2015%20Boletin%20epidemiologico%20Semana%2052.pdf
Peñuela-Epalza M, Vásquez-Beltrán M, De La Rosa-Barraza K, Hernández-Tapia H, Collazos-Daza J, Yanes-Miranda Y. Factores asociados a la coinfección VIH/SIDAtuberculosis. Salud Uninorte. 2006;22:5-19.
Villarroel L, Rabagliati R, Balcells ME, Karzulovic L, Pérez C. Tuberculosis en individuos con infección por VIH en Chile: estudio de prevalencia e impacto sobre mortalidad. Rev Med Chil. 2008;136:578-86. https://doi.org/10.4067/S0034-98872008000500005
Laguardia J, Merchán-Hamann E. Factores de riesgo para la enfermedad tuberculosa en los casos de sida notificados en Brasil, 1980 a 2000. Rev Esp Salud Pública. 2003;77:553-65.
Organización Panamericana de la Salud. Manual para el diagnóstico bacteriológico de la tuberculosis. Organización Panamericana de la Salud - 2008. Fecha de consulta:
de noviembre de 2015. Disponible en: iris.paho.org/xmlui/bitstream/handle/123456789/782/9789275330135.pdf?sequence=1&isAllowed=y.
World Health Organization. Global tuberculosis report 2014. Fecha de consulta: 1 de octubre de 2015. Disponible en: apps.who.int/iris/bitstream/10665/137094/1/9789241564809_
eng.pdf
Ministerio de Salud. Resolución Número 1078 de 2000. Fecha de consulta: 12 de febrero de 2016. Disponible en: https://www.minsalud.gov.co/sites/rid/Lists/
BibliotecaDigital/RIDE/DE/DIJ/Resoluci%C3%B3n_1078_de_2000.pdf
López-Álvarez R, Badillo-López C, Cerna-Cortés JF, Castillo-Ramírez I, Rivera-Gutiérrez S, Helguera-Repetto AC, et al. First insights into the genetic diversity of Mycobacterium tuberculosis isolates from HIV-infected Mexican patients and mutations causing multidrug resistance. BMC Microbiol. 2010;10:82. https://doi.org/10.1186/1471-2180-10-82
Martinson NA, Hoffmann CJ, Chaisson RE. Epidemiology of tuberculosis and HIV: Recent advances in understanding and responses. Proc Am Thorac Soc. 2011;8:288-93.
https://doi.org/10.1513/pats.201010-064WR
World Health Organization. HIV/AIDS: 2015. Fecha de consulta: 25 de enero 25 de 2016. Disponible en: http://www.who.int/mediacentre/factsheets/fs360/en/
Crespo MP, Heli-Corral R, Alzate A, Carrasquilla G, Sánchez N. Mycobacterial infections in HIV-infected patients in Cali, Colombia. Rev Panam Salud Pública. 1999;6:249-55.
Murcia-Aranguren MI, Gómez-Marín JE, Alvarado FS, Bustillo JG, de Mendivelson E, Gómez B, et al. Frequency of tuberculous and non-tuberculous mycobacteria in HIV infected patients from Bogotá, Colombia. BMC Infect Dis. 2001;1:21.
Schmaltz CA, Santoro-Lopes G, Lourenço MC, Morgado MG, Velasque Lde S, Rolla VC. Factors impacting early mortality in tuberculosis/HIV patients: Differences between subjects naive to and previously started on HAART. PloS One. 2012;7:e45704. https://doi.org/10.1371/journal.pone.0045704
Taha M, Deribew A, Tessema F, Assegid S, Duchateau L, Colebunders R. Risk factors of active tuberculosis in people living with HIV/AIDS in Southwest Ethiopia: A case control study. Ethiop J Health Sci. 2011;21:131-9.
Murcia MI, León CI, de la Hoz F, Saravia J. Mycobacteria-HIV/AIDS association in patients attending a teachinghospital in Bogotá, Colombia. Rev Salud Pública. 2007;9:97-105. https://doi.org/10.1590/S0124-00642007000100010
Arenas NE, Ramírez N, González G, Rubertone S, García AM, Gómez-Marínc JE, et al. Estado de la coinfección tuberculosis/virus de la inmunodeficiencia humana en el municipio de Armenia (Colombia): experiencia de 10 años. Infectio. 2012;16:140-7.
Hoza AS, Mfinanga SG, Rodloff AC, Moser I, Konig B. Increased isolation of nontuberculous mycobacteria among TB suspects in Northeastern, Tanzania: Public health and diagnostic implications for control programmes. BMC Res Notes. 2016;9:109. https://doi.org/10.1186/s13104-016-1928-3
Kobayashi T, Nishijima T, Teruya K, Aoki T, Kikuchi Y, Oka S, et al. High mortality of disseminated non-tuberculous mycobacterial infection in HIV-infected patients in the antiretroviral therapy era. PloS One. 2016;11:e0151682. https://doi.org/10.1371/journal.pone.0151682
Lan R, Yang C, Lan L, Ou J, Qiao K, Liu F, et al. Mycobacterium tuberculosis and non-tuberculous mycobacteria isolates from HIV-infected patients in Guangxi, China. Int J Tuberc Lung Dis. 2011;15:1669-75. https://doi.org/10.5588/ijtld.11.0036
Lannoy LH, Cortéz-Escalante JJ, Evangelista MS, Romero GA. Tuberculosis incidence and risk factors among patients living with HIV/AIDS in public health service institutions in Brasilia, Federal District. Rev Soc Bras Med Trop. 2008;41:549-55. https://doi.org/10.1590/S0037-86822008000600001
Some similar items:
- Adriana Rojas-Villarraga, Carlos Andrés Agudelo, Ricardo Pineda-Tamayo, Alvaro Porras, Gustavo Matute, Juan Manuel Anaya, Tuberculosis in patientes treated with tumor necrosis factor alpha antagonists living in an endemic area. Is the risk worthwhile? , Biomedica: Vol. 27 No. 2 (2007)
- Marlene Reyes, Ángela Torres, Lyda Esteban, Mónica Flórez, Víctor Manuel Angulo, Risk of transmission of Chagas disease by intrusion of triatomines and wild mammals in Bucaramanga, Santander, Colombia , Biomedica: Vol. 37 No. 1 (2017)
- Alvaro Javier Idrovo, Historical, social and epidemiological roots of tuberculosis in Bogotá, Colombia. , Biomedica: Vol. 24 No. 4 (2004)
- Carlos A. Torres-Duque, Claudia Díaz, Leslie Vargas, Elsa María Serpa, Walter Mosquera, María Consuelo Garzón, Graciela Mejía, Luz Mary García, Liliana Andrea González, Claudia Marcela Castro, Wellman Ribón, Disseminated mycobacteriosis affecting a prosthetic aortic valve: first case of Mycobacterium peregrinum type III reported , Biomedica: Vol. 30 No. 3 (2010)
- Mónica Marcela Jiménez, Jesús Arias, Gabriel Carrasquilla, Seroprevalence of dengue infection in the municipalities of Armenia, Calarcá, La Tebaida and Montenegro in Quindío, 2014 , Biomedica: Vol. 37 No. 1 (2017)
- Leandro Galvis, Ángel Y. Sánchez, Leonardo F. Jurado, Martha I. Murcia, Tuberculosis associated with tumor necrosis factor-α antagonists, case description and analysis of reported cases in Colombia , Biomedica: Vol. 38 No. 1 (2018)
- María Isabel Bermúdez-Forero, Maritza Berrío-Pérez, Andrea Magally Herrera-Hernández, Magda Juliana Rodríguez-Rodríguez, Sandra García-Blanco, Guillermo Orjuela-Falla, Mauricio Beltrán, Prevalence of human T-cell lymphotropic virus I and II in Colombian blood donors, 2001-2014: Implications for transfusion safety , Biomedica: Vol. 36 (2016): Suplemento 2, Enfermedades virales
- Diana Marcela Echeverry, Juan Miguel Rengifo, Jhon Carlos Castaño, Germán Alberto Téllez, María Mercedes González, Prevalence of Mammomonogamus laryngeus (Strongylida: Syngamidae) nematodes in a bovine slaughterhouse , Biomedica: Vol. 31 No. 3 (2011)
- Guillermo Mora, María Clara Echeverry, Gustavo Enrique Rey, Myriam Consuelo López, Luisa Fernanda Posada, Fabio Aurelio Rivas, Frequency of Trypanosoma cruzi infection in patients with implanted pacemaker , Biomedica: Vol. 27 No. 4 (2007)
- Juan Gabriel Bueno-Sánchez, Jairo René Martínez-Morales, Elena E. Stashenko, Wellman Ribón, Anti-tubercular activity of eleven aromatic and medicinal plants occurring in Colombia , Biomedica: Vol. 29 No. 1 (2009)
| Article metrics | |
|---|---|
| Abstract views | |
| Galley vies | |
| PDF Views | |
| HTML views | |
| Other views | |
